| Item Type | Name |
|
Academic Article
|
Impact of clinical complexity on the quality of diabetes care.
|
|
Academic Article
|
Non-high-density lipoprotein cholesterol reporting and goal attainment in primary care.
|
|
Concept
|
Veterans
|
|
Concept
|
United States Department of Veterans Affairs
|
|
Concept
|
Hospitals, Veterans
|
|
Academic Article
|
Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions.
|
|
Academic Article
|
Is high-intensity statin therapy associated with lower statin adherence compared with low- to moderate-intensity statin therapy? Implications of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guidelines.
|
|
Academic Article
|
Metrics of quality care in veterans: correlation between primary-care performance measures and inappropriate myocardial perfusion imaging.
|
|
Academic Article
|
Implications for Ezetimibe Therapy Use Based on IMPROVE-IT Criteria.
|
|
Academic Article
|
Calculations of Financial Incentives for Providers in a Pay-for-Performance Program: Manual Review Versus Data From Structured Fields in Electronic Health Records.
|
|
Academic Article
|
Effect of Long-Term Periodontal Care on Hemoglobin A1c in Type 2 Diabetes.
|
|
Academic Article
|
Statin Use and Its Facility-Level Variation in Patients With Diabetes: Insight From the Veterans Affairs National Database.
|
|
Academic Article
|
Lipid Management Guidelines from the Departments of Veteran Affairs and Defense: A?Critique.
|
|
Academic Article
|
Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Peripheral Arterial and Ischemic Cerebrovascular Disease Compared to Veterans With Coronary Heart Disease.
|
|
Academic Article
|
Comparative effectiveness of outpatient cardiovascular disease and diabetes care delivery between advanced practice providers and physician providers in primary care: Implications for care under the Affordable Care Act.
|
|
Academic Article
|
Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease.
|
|
Academic Article
|
Use of high-intensity statins for patients with atherosclerotic cardiovascular disease in the Veterans Affairs Health System: Practice impact of the new cholesterol guidelines.
|
|
Academic Article
|
Estimation of Eligibility for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and Associated Costs Based on the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk): Insights From the Department of Veterans Affairs.
|
|
Academic Article
|
Health Care Resource Utilization for Outpatient Cardiovascular Disease and Diabetes Care Delivery Among Advanced Practice Providers and Physician Providers in Primary Care.
|
|
Academic Article
|
Facility-level variation in diabetes and blood pressure control in patients with diabetes: Findings from the Veterans Affairs national database.
|
|
Academic Article
|
Statin prescription rates and their facility-level variation in patients with peripheral artery disease and ischemic cerebrovascular disease: Insights from the Department of Veterans Affairs.
|
|
Academic Article
|
Impact of Patient-Centered Medical Home Implementation on Diabetes Control in the Veterans Health Administration.
|
|
Academic Article
|
Frequency of Statin Use in Patients With Low-Density Lipoprotein Cholesterol =190 mg/dl from the Veterans Affairs Health System.
|
|
Academic Article
|
Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease.
|
|
Academic Article
|
Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD.
|
|
Academic Article
|
Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial.
|
|
Academic Article
|
Association of Body Mass Index With Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Cardiovascular Disease.
|
|
Academic Article
|
Eligibility and Cost for Icosapent Ethyl Based on the REDUCE-IT Trial.
|
|
Academic Article
|
Facility-Level Variation in Stress Test Utilization in Veterans With Ischemic Heart Disease.
|
|
Concept
|
Veterans Health
|
|
Academic Article
|
Association Between Lipid Testing and Statin Adherence in the Veterans Affairs Health System.
|
|
Academic Article
|
Relation Between Cardiology Follow-Up Visits, Evidence-Based Statin Prescribing, and Statin Adherence (from the Veterans Affairs Health Care System).
|
|
Academic Article
|
The use of structured data elements to identify ASCVD patients with statin-associated side effects: Insights from the Department of Veterans Affairs.
|
|
Academic Article
|
Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program.
|
|
Academic Article
|
Association between frequency of primary care provider visits and evidence-based statin prescribing and statin adherence: Findings from the Veterans Affairs system.
|
|
Academic Article
|
Impact of Lipid Monitoring on Treatment Intensification of Cholesterol Lowering Therapies (from the Veterans Affairs Healthcare System).
|
|
Academic Article
|
Facility-Level Variation in Cardiac Stress Test Use Among Patients With Diabetes: Findings From the Veterans Affairs National Database.
|
|
Academic Article
|
Obesity and the paradox of mortality and heart failure hospitalization in heart failure with preserved ejection fraction.
|
|
Academic Article
|
Statin Prescription Rates, Adherence, and Associated Clinical Outcomes Among Women with PAD and ICVD.
|
|
Academic Article
|
Eligibility for Low-Dose Rivaroxaban Based on the COMPASS Trial: Insights from the Veterans Affairs Healthcare System.
|
|
Academic Article
|
Significant Facility-Level Variation in Utilization of and Adherence with Secondary Prevention Therapies Among Patients with Premature Atherosclerotic Cardiovascular Disease: Insights from the VITAL (Veterans wIth premaTure AtheroscLerosis) Registry7.
|
|
Academic Article
|
Facility-Level Variation in Reported Statin-Associated Side Effects Among Patients with Atherosclerotic Cardiovascular Disease-Perspective from the Veterans Affair Healthcare System.
|
|
Academic Article
|
Sex-Related Disparities in Cardiovascular Health Care Among Patients With Premature Atherosclerotic Cardiovascular Disease.
|
|
Academic Article
|
Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) guidelines for management of dyslipidemia and cardiovascular disease risk reduction: Putting evidence in context.
|
|
Academic Article
|
Association of patient, provider and facility related characteristics with statin associated side effects and statin use: Insight from the Veteran's Affairs healthcare system.
|
|
Academic Article
|
Effects of the 2021 CKD-EPI Creatinine eGFR Equation among a National US Veteran Cohort.
|
|
Academic Article
|
Correlates of SGLT-2-inhibitiors use among patients with atherosclerotic cardiovascular disease and type 2 diabetes mellitus: Insights from the department of veterans affairs.
|
|
Academic Article
|
Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs.
|
|
Academic Article
|
Correlates of Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus (from the Department of Veterans Affairs).
|
|
Academic Article
|
Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease.
|
|
Academic Article
|
Predictors, Disparities, and Facility-Level Variation: SGLT2 Inhibitor Prescription Among US Veterans With CKD.
|
|
Academic Article
|
Lipid-Lowering Therapy Use and Intensification Among United States Veterans Following Myocardial Infarction or Coronary Revascularization Between 2015 and 2019.
|
|
Academic Article
|
Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans Affairs.
|
|
Academic Article
|
Association Between Historical Neighborhood Redlining and Cardiovascular Outcomes Among US Veterans With Atherosclerotic Cardiovascular Diseases.
|
|
Academic Article
|
Racial and Ethnic Disparities and Facility-Level Variation in GLP-1 RA Prescription among US Veterans with CKD.
|
|
Academic Article
|
Association of Atherosclerotic Cardiovascular Disease, Hypertension, Diabetes, and Hyperlipidemia With Gulf War Illness Among Gulf War Veterans.
|